Selecting new upfront regimens for advanced ovarian cancer with biomarker guidance. Chan JK, Liang SY, Kapp DS, Chan JE, et al. Gynecol Oncol 2020 Sep 26. pii: S0090-8258(20)33910.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chan JK, Liang SY, Kapp DS, Chan JE, et al. Selecting new upfront regimens for advanced ovarian cancer with biomarker guidance. Gynecol Oncol 2020 Sep 26. pii: S0090-8258(20)33910.
PMID: 32994055